Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Laura J Rojas"'
Autor:
Elsa De la Cadena, María Fernanda Mojica, Laura J. Rojas, Betsy E. Castro, Juan Carlos García-Betancur, Steven H. Marshall, Natalia Restrepo, Nancy Patricia Castro-Caro, Magalis Fonseca-Carrillo, Christian Pallares, Robert A. Bonomo, María Virginia Villegas
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 6 (2024)
ABSTRACT Resistance to ceftazidime-avibactam (CZA) due to Klebsiella pneumoniae carbapenemase (KPC) variants is increasing worldwide. We characterized two CZA-resistant clinical Klebsiella pneumoniae strains by antimicrobial susceptibility test, conj
Externí odkaz:
https://doaj.org/article/8cf3293634cf4f1d8c1bdfe4270d61b4
Autor:
Elsa De La Cadena, Mateo Mahecha, Ana María Velandia, Juan Carlos García-Betancur, Laura J. Rojas, Jessica Porras, Christian Pallares, María Virginia Villegas
Publikováno v:
Antibiotics, Vol 12, Iss 3, p 488 (2023)
We report the presence of the mcr-1 gene among 880 Escherichia coli clinical isolates collected in 13 hospitals from 12 Colombian cities between 2016 and 2019. Seven (0.8%) isolates were colistin resistant (MIC ≥ 4 µg/mL). These colistin-resistant
Externí odkaz:
https://doaj.org/article/5f2a9db4c47a440bbc4e191781b17981
Autor:
Abdullah Kilic, Shermalyn R. Greene, Laura J. Rojas, Steven H. Marshall, Susan D. Rudin, Robert A. Bonomo, Michael R. Jacobs, Elizabeth Palavecino
Publikováno v:
Journal of Global Antimicrobial Resistance, Vol 25, Iss , Pp 154-156 (2021)
Externí odkaz:
https://doaj.org/article/020e5b9704e641b4926bb61271d5ce82
Autor:
Laura J Rojas, Mohamad Yasmin, Jacquelynn Benjamino, Steven M Marshall, Kailynn J DeRonde, Nikhil P Krishnan, Federico Perez, Andrew A Colin, Monica Cardenas, Octavio Martinez, Armando Pérez-Cardona, Daniel D Rhoads, Michael R Jacobs, John J LiPuma, Michael W Konstan, Alejandro J Vila, Andrea Smania, Andrew R Mack, Jacob G Scott, Mark D Adams, Lilian M Abbo, Robert A Bonomo
Publikováno v:
PLoS ONE, Vol 17, Iss 3, p e0265129 (2022)
BackgroundPseudomonas aeruginosa is a persistent and difficult-to-treat pathogen in many patients, especially those with Cystic Fibrosis (CF). Herein, we describe a longitudinal analysis of a series of multidrug resistant (MDR) P. aeruginosa isolates
Externí odkaz:
https://doaj.org/article/b792cfbcd3cf4cadae6ebcb48376470a
Autor:
Morgan K. Morelli, Amy Kloosterboer, Scott A. Fulton, Jennifer Furin, Nicholas Newman, Ahmed F. Omar, Laura J. Rojas, Steven H. Marshall, Mohamad Yasmin, Robert A. Bonomo
Publikováno v:
Antimicrobial Agents and Chemotherapy.
Resistant Gram-negative bacteria are a growing concern in the United States, leading to significant morbidity and mortality. We identified a 72-year-old female patient who presented with unilateral vision loss.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::75f4c33494b376d8452b1b9a509b5092
https://doi.org/10.1128/aac.00277-23
https://doi.org/10.1128/aac.00277-23
Autor:
Elsa De La Cadena, María Fernanda Mojica, Juan Carlos García-Betancur, Tobías Manuel Appel, Jessica Porras, Christian José Pallares, Juan Sebastián Solano-Gutiérrez, Laura J. Rojas, María Virginia Villegas
Publikováno v:
Antibiotics, Vol 10, Iss 3, p 284 (2021)
Polymyxin resistance in Klebsiella pneumoniae has been attributed to mutations in mgrB, phoPQ, pmrAB, and crrAB and to the presence of mcr plasmid-mediated genes. Herein, we describe the molecular characteristics of 24 polymyxin- and carbapenem-resis
Externí odkaz:
https://doaj.org/article/9d2c705ccbc642649ea92ea23e261b55
Autor:
Robert A. Bonomo, Glenn D. Wera, Steven H. Marshall, Robin L.P. Jump, Taissa Bej, Mohamad Yasmin, Brandon S. Twardy, Laura J. Rojas
Publikováno v:
Surgical Infections. 23:84-88
Background: A 72-year-old male developed a late-onset infection of an internal fixation device caused by Microbacterium oxydans. Although often considered contaminants, bacteria from the genus Micr...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5172a249ea904a50c2e239e03c385ff2
https://doi.org/10.1089/sur.2021.133
https://doi.org/10.1089/sur.2021.133
Autor:
Mohamad Yasmin, Laura J Rojas, Steven H Marshall, Andrea M Hujer, Anna Cmolik, Emma Marshall, Helen W Boucher, Alejandro J Vila, Maxime Soldevila, Seydina M Diene, Jean-Marc Rolain, Robert A Bonomo
Publikováno v:
Open Forum Infect Dis
Open Forum Infectious Diseases
Open Forum Infectious Diseases, 2023, 10 (2), pp.ofad014. ⟨10.1093/ofid/ofad014⟩
Open Forum Infectious Diseases
Open Forum Infectious Diseases, 2023, 10 (2), pp.ofad014. ⟨10.1093/ofid/ofad014⟩
BackgroundElizabethkingia anophelis is an emerging Gram-negative nonlactose fermenter in the health care setting, where it causes life-threatening infections in immunocompromised patients. We aimed to characterize the molecular mechanisms of antimicr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb9e88a69621f9d08160de3f0eba0f9f
https://europepmc.org/articles/PMC9938519/
https://europepmc.org/articles/PMC9938519/
Autor:
Tahani A. Alsenani, María Margarita Rodríguez, Barbara Ghiglione, Magdalena A. Taracila, Maria F. Mojica, Laura J. Rojas, Andrea M. Hujer, Gabriel Gutkind, Christopher R. Bethel, Philip N. Rather, Maria Luisa Introvigne, Fabio Prati, Emilia Caselli, Pablo Power, Focco van den Akker, Robert A. Bonomo
Publikováno v:
Antimicrobial Agents and Chemotherapy. 67
Design of novel β-lactamase inhibitors (BLIs) is one of the currently accepted strategies to combat the threat of cephalosporin and carbapenem resistance in Gram-negative bacteria. B oronic a cid t ransition s tate i nhibitors (BATSIs) are competiti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3496510e598e14b9d68654f2f368061
https://doi.org/10.1128/aac.00930-22
https://doi.org/10.1128/aac.00930-22
Autor:
Mohamad Yasmin, Liang Chen, Steven Marshall, Daniel D Rhoads, Michael R Jacobs, Laura J Rojas, Federico Perez, Andrea M Hujer, Barry N Kreiswirth, Robert A Bonomo
Publikováno v:
Open Forum Infectious Diseases. 9
Background Meropenem-vaborbactam (MV) is the first carbapenem/β-lactamase inhibitor combination developed to restore meropenem susceptibility against KPC-producing carbapenem-resistant Enterobacterales(CRE). Vaborbactam (VAB) potently inhibits Amble
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::659ed1783370b17f135b7ee0ad02207e
https://doi.org/10.1093/ofid/ofac492.220
https://doi.org/10.1093/ofid/ofac492.220